Ranbaxy Loses Bid To Make Generic Flomax

Law360 (February 23, 2007, 12:00 AM EST) -- A U.S. federal judge has squashed an attempt by Indian generic drug maker Ranbaxy Laboratories Ltd. to make its own version of Flomax, the enlarged-prostate treatment developed by Japanese pharmaceutical firm Astellas Pharma Inc.

The decision, issued Feb. 21 by Judge Mary L. Cooper in New Jersey District Court, was also a victory for Boehringer Ingelheim Pharmaceuticals Inc., the Ridgefield, Conn.-based company that markets Flomax in the United States.

Ranbaxy filed a notice with the court on Thursday that it was appealing the decision to the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.